This activity is provided by Global Education Group. Paradigm Medical Communications, LLC, is the educational partner.
This activity is supported by an educational grant from Genentech, Inc.
Giant cell arteritis (GCA) is a rare disease with presenting symptoms that are common to other diseases— headache and vision disturbances. The potential for rapid irreversible vision loss make GCA one of the few rheumatologic emergencies. Clinicians need to be aware of the symptoms of GCA, so they are prepared to consider GCA to make a rapid diagnosis and initiate appropriate therapy. This educational activity includes case-based and expert-led review of the data supporting a reduction in diagnostic delay, best practices evaluating large-vessel disease, and education on new and emerging agents to prevent relapse in order to promote effective, efficient, and safe care for patients with GCA; it also includes a Fast Track evaluation tool to establish office processes to help clinical staff identify patients in need of rapid evaluation for GCA, as well as a clinical diagnostic and monitoring Clinical Checklist that can be added to the electronic medical records to help guide evaluation of patients with GCA.
This activity has been designed to address the educational needs of clinicians involved in the management of patients with GCA, including those consulted on diagnosis and management, and those who refer patients for consultation.
Upon proper completion of this activity, participants should be better able to:
Clinicians with patients with suspected GCA in need of referral should be better able to recognize early signs and symptoms of giant cell arteritis, which indicate the need for urgent referral to another specialist.
Clinicians consulted on the diagnosis and management of GCA should be better able to prioritize referrals to address the emergent nature of giant cell arteritis.
Clinicians consulted on the diagnosis and management of GCA should be better able to evaluate the utility of available diagnostic and imaging modalities for large-vessel involvement in giant cell arteritis.
All clinicians should be better able to compare evidence for new and emerging therapies to manage giant cell arteritis and reduce the risk of relapse.
Conflict Of Interest Disclosure Policy
Global Education Group (Global) and Paradigm Medical Communications, LLC, (Paradigm) require instructors, planners, managers, and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global and Paradigm for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices, they or their spouses/life partners have with commercial interests related to the content of this CME activity:
Rebecca L. Manno, MD, MHS Assistant Professor of Medicine Division of Rheumatology Department of Medicine The Johns Hopkins University School of Medicine Assistant Director, The Johns Hopkins Vasculitis Center Baltimore, MD
Dr. Manno discloses the following: Consultant/Independent Contractor: sanofi-aventis U.S. LLC
Sebastian H. Unizony, MD Assistant Professor of Medicine Division of Rheumatology Department of Medicine Harvard Medical School Co-Director, Vasculitis and Glomerulonephritis Center Harvard Medical School – Massachusetts General Hospital Boston, MA
Dr. Unizony discloses the following: Consultant/Independent Contractor: Kiniksa Pharmaceuticals, Corp.; sanofi-aventis U.S. LLC Grant/Research Report: Genentech, Inc.
Faculty Consultant Joseph F. Rizzo III, MD David Glendenning Cogan Professor of Ophthalmology Harvard Medical School Director, Neuro-Ophthalmology Service Co-director, Mobility Enhancement and Vision Rehabilitation Center of Excellence Massachusetts Eye and Ear Boston, MA
Dr. Rizzo has no financial relationships to disclose.
Joyce Dietrich, MD Assistant Professor of Medicine and Pediatrics Johns Hopkins University School of Medicine Baltimore, MD
Dr. Dietrich has no financial relationships to disclose.
Accredited Provider Disclosure
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Lindsay Borvansky has no financial relationships to disclose. Liddy Knight has no financial relationships to disclose. Andrea Funk has no financial relationships to disclose. Ashley Cann has no financial relationships to disclose. Tara Brant has no financial relationships to disclose. Sally Haas has no financial relationships to disclose. Will Riley has no financial relationships to disclose. Elizabeth McSpiritt has no financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments Database.
Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Paradigm do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
To receive a CME certificate of participation, participants must:
Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pre-activity assessment.
View the online activity in its entirety.
Complete and submit the online post-activity assessment and evaluation.
A certificate of participation will be available for download/printing immediately following your successful completion of the post-activity assessment and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your myCME CME History.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
For information about the accreditation of this program, please contact Global Education Group at (303) 395-1782 or email@example.com.
There is no fee required for participation in this activity.
Disclaimer The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Global Education Group or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global or Paradigm. Global and Paradigm accept no liability for the content referenced in this activity.
Security/safeguarding personal information This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Global and Paradigm to continuously improve the learning experience.
Global Education Group and Paradigm Medical Communications, LLC, do not transfer, sell, or share personal information with outside parties. Global and Paradigm will not otherwise disclose personal information unless required to in a legal process. Global and Paradigm staff members review individual test results to the extent necessary to record and track participants’ credits.